FOR INVESTORS

 Publications

INDEX OF ARTICLES

Muehlbauer, PM, Klapec, K, Locklin, J, George, ME, Cunningham, L, Gottschalk, C, Seidel, GD: Part II: Nursing Implications of Administering Chemotherapy in Interventional Radiology or the Operating Room: Clinical Journal of Oncology Nursing 2006, 10: 345-356....>>>

Bowles, Claire: NEW SCIENTIST MAGAZINE ISSUE: 29 SEPTEMBER 2007....>>>

Seidel, GD, Locklin, J, Muehlbauer, PM,: Part I: Regional Chemotherapy Clinical Studies in Nontraditional Clinical Settings: Clinical Journal of Oncology Nursing 2006, 10: 338-344

Pingpank, JF, Libutti, SK, Chang, R, Wood, BJ, Neeman, Z, Kam, AW, Figg, WD, Zhai, S, Beresneva, T, Seidel, GD, Alexander, HR: Phase I Study of Hepatic Arterial Melphalan Infusion and Hepatic Venous Hemofiltration Using Percutaneously Placed Catheters in Patients With Unresectable Hepatic Malignancies. J Clin Oncol 23:3465-3474, 2005...>>>

Ravikumar TS, Pizzorno G, Bodden W, Marsh J, Strair R, Pollack J, Hendler R, Hanna J, DíAndrea E: Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors: Journal of Clinical Oncology 1994; 12:2723-2736.

Curley SA, Newman RA, Dougherty T, Fuhrman GM, Stone DL, Mikolajek JA, Guercio S, Guercio A, Carrasco CH, Kuo MT, Hohn DC: Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: a phase I study. Annals of Surgical Oncology 1994; 1(5):389-399.

Beheshti MV, Denny DF, Glickman MG, Bodden W, Marsh JC, Strair R, Ravikumar TS: Percutaneous isolated liver perfusion for treatment of hepatic malignancy: Preliminary Report. Journal of Vascular and Interventional Radiology 1992;3:453-458.

Lowy AM, Curley SA: Clinical and preclinical trials of isolated liver perfusion for advanced liver tumors. Surg Oncol Clinics NA, 1996; 429-441. Ravikumar TS, Dixon MS: Isolated liver perfusion for liver metastases. Surg Oncol Clinics NA, 1996; 443-449.

August D, Verma N, Andrews, Vaertan MA, Brenner DE: Hepatic artery infusion of doxorubicin with hepatic venous drug extraction. Journal of Surgical Research 1994; 56:611-619.

August D, Verma N, Vaertan MA, Shah R, Brenner DE: An evaluation of hepatic extraction and clearance of doxorubicin. British Journal of Cancer 1995;72: 65-71.

Curley SA, Byrd DR, Newman RA, Ellis HJ, Chase J, Carrasco CH, Cleary K, Bodden W, Hohn DC: Reduction of systemic drug exposure following hepatic arterial infusion of doxorubicin with complete hepatic venous isolation and extracorporeal chemofiltration. Surgery 1993;114: 579-85.

Curley SA, Stone DL, Fuhrman GM, Hohn DC, Siddik ZH, Newman RA: Increased doxorubicin levels in hepatic tumors with reduced systemic drug exposure achieved with complete hepatic venous isolation and extracorporeal chemofiltration. Cancer Chemotherapy Pharmacology 1933; 33(3):251-257.

Fuhrman GM, Hohn DC, Curley SA: High-dose hepatic arterial adriamycin with systemic protection provided by a novel hepatic venous isolation catheter and extracorporeal chemofiltration. Surgical Forum 1992; 43:440-442.

Curley SA, Byrd DR, Newman RA, Carrasco CH, Cromeens D, Ellis HJ, Chase J, Dougherty T, Wright K, Bodden W, Hohn DC: Hepatic arterial infusion chemotherapy with complete hepatic venous isolation and extracorporeal chemofiltration: A feasibility study of a novel system. Anti-Cancer Drugs 1991; 2:175-183.